Predicted protein targets (top 17)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CA1 | P00915 | 4/20 | 0.47 |
| ▸ | CA2 | P00918 | 4/20 | 0.47 |
| ▸ | CA7 | P43166 | 2/20 | 0.47 |
| ▸ | CA13 | Q8N1Q1 | 1/20 | 0.47 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.38 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.38 |
| ▸ | F2 | P00734 | 1/20 | 0.35 |
| ▸ | PRSS1 | P07477 | 1/20 | 0.35 |
| ▸ | PRSS2 | P07478 | 1/20 | 0.35 |
| ▸ | PRSS3 | P35030 | 1/20 | 0.35 |
| ▸ | CA5A | P35218 | 2/20 | 0.32 |
| ▸ | CA9 | Q16790 | 2/20 | 0.32 |
| ▸ | TSHR | P16473 | 1/20 | 0.32 |
| ▸ | NT5E | P21589 | 1/20 | 0.32 |
| ▸ | CA4 | P22748 | 1/20 | 0.32 |
| ▸ | CA6 | P23280 | 1/20 | 0.32 |
| ▸ | CA5B | Q9Y2D0 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL16369621 | 0.77 | ALDH1A1 (0.57) | CA1CA2CA7CA13ALDH1A1 | |
| SCHEMBL501588 | 0.77 | ALDH1A1 (0.57) | CA1CA2CA7CA13ALDH1A1 | |
| SCHEMBL19865186 | 0.77 | ALDH1A1 (0.38) | CA1CA2CA7CA13ALDH1A1 | |
| SCHEMBL13495722 | 0.77 | CA1 (0.47) | CA1CA2CA7CA13ALDH1A1 | |
| SCHEMBL12417902 | 0.74 | CA1 (0.45) | CA1CA2CA7CA13ALDH1A1 | |
| SCHEMBL4418986 | 0.73 | CA1 (0.50) | CA1CA2CA7CA13ALDH1A1 | |
| SCHEMBL1149367 | 0.69 | TDP1 (0.35) | CA1CA2CA7CA13ALDH1A1 | |
| SCHEMBL10260605 | 0.69 | CA2 (0.44) | CA1CA2CA7CA13ALDH1A1 | |
| SCHEMBL12211903 | 0.69 | CA1 (0.39) | CA1CA2CA7CA13ALDH1A1 | |
| SCHEMBL16914858 | 0.67 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-7659026-B2 | membrane electrodes; electrocatalysts; fuel cells | E.I. DU PONT DE NEMOURS AND COMPANY (US) | 2010-02-09 | — | — | US | disclosed |
| US-20060178411-A1 | Sulfonimide containing compounds and their use in polymer electrolyte membranes for electrochemical cells | E. I. DU PONT DE NEMOURS AND COMPANY | 2006-08-10 | — | — | US | disclosed |
| US-20060177717-A1 | Fluorinated sulfonamide compounds and polymer electrolyte membranes prepared therefrom for use in electrochemical cells | U.S. DEPARTMENT OF ENERGY | 2006-08-10 | — | — | US | disclosed |
| WO-2005003081-A2 | SULFONIMIDE CONTAINING COMPOUNDS AND THEIR USE IN POLYMER ELECTROLYTE MEMBRANES FOR ELECTROCHEMICAL CELLS | E.I. DUPONT DE NEMOURS AND COMPANY (US) | 2005-01-13 | — | — | WO | disclosed |
| WO-2005001979-A2 | FLUORINATED SULFONAMIDE COMPOUNDS AND POLYMER ELECTROLYTE MEMBRANES PEPARED THEREFROM FOR USE IN ELECTROCHEMICAL CELLS | E.I. DUPONT DE NEMOURS AND COMPANY (US) | 2005-01-06 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20060178411-A1 | Sulfonimide containing compounds and their use in polymer electrolyte membranes for electrochemical cells | HCN2, KCNN2, NHERF1 | CA1 22/4885CA2 12/4885CA7 227/4885 |
| US-20060177717-A1 | Fluorinated sulfonamide compounds and polymer electrolyte membranes prepared therefrom for use in electrochemical cells | PEF1, NHERF1, PXMP4 | CA1 281/4885CA2 165/4885CA7 507/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.